AdvanSix Q2 Earnings: A 3% Revenue Rise That Masks a 600-Basis-Point Margin Collapse

The headline from AdvanSix's second-quarter results reads like a recovery. Revenue rose 3% to $421 million. The company declared its $0.16 quarterly dividend. Management spoke about controllable levers and sequential cash-flow improvement ahead.

But the numbers underneath tell a different story — one where an 18% pricing increase is entirely about passing on higher raw material costs, volumes have collapsed 15%, and adjusted EBITDA margin has been slashed in half. This is not a company raising prices because it has pricing power. This is a company trying to survive input inflation while its largest segment bleeds volume.

From an income and risk/reward point of view, the 3.17% dividend yield looks attractive on a spreadsheet. But yield means nothing without payout durability. And that is the question AdvanSix's Q2 results force us to confront.

The Pricing Illusion

Let's break down what drove that 3% revenue increase. AdvanSix reported an 18% favorable pricing effect, which sounds like pricing power until you look at the composition. Thirteen percentage points came from raw material pass-through pricing — essentially the company passing higher benzene and propylene costs (inputs to cumene, a key nylon feedstock) directly to customers. The remaining 5% came from market-based pricing in Plant Nutrients, driven by higher nitrogen and sulfur input costs.

None of this is organic pricing power. If you can only raise prices because your costs forced you to, you don't have a moat — you have a pass-through model with razor-thin economics. And the proof is in the margins. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization, a rough proxy for cash earnings) fell 43% year-over-year to $31.9 million. The adjusted EBITDA margin contracted from 13.6% to 7.6%, a 600-basis-point collapse.

Gross profit fell roughly 47% to approximately $31.1 million, with the gross margin dropping from about 14.3% to 7.4%. Meanwhile, cost of goods sold rose from $351.3 million to $390.2 million. The company passed on more cost, lost more volume, and earned significantly less for every dollar of revenue. That is not pricing power. That is margin erosion in disguise.

Volume Collapse Is the Real Story

The 15% volume decline is where this quarter turns from disappointing to alarming. And the single biggest driver is Plant Nutrients, which accounts for 31% of revenue and saw sales plummet 16% to $131.4 million.

The problem is straightforward: farmer economics are challenging. In-season fertilizer purchases for ammonium sulfate — AdvanSix's flagship plant nutrient product — were down sharply. The company's own guidance for Q3 warns that North America's ammonium sulfate fill program is expected to drive sequential domestic pricing declines amid competitive conditions and continued high sulfur input costs.

That is a brutal setup. The input cost (sulfur) is elevated, the product price is expected to fall sequentially, and volumes are already weak. Three quarters into 2026, Plant Nutrients has gone from a margin contributor to a margin destroyer. In Q1, adjusted EBITDA for the entire company was just $4.8 million on $404 million in revenue — a 1.2% margin. In Q2, it recovered to $31.9 million, but that's from an unusually low base and still represents half the margin of a year ago.

What About Nylon and Chemical Intermediates?

Here is where the story gets slightly more interesting. Nylon Solutions revenue jumped 26% to $100.2 million, and Chemical Intermediates grew 18% to $126.9 million. Both segments performed at or above management's expectations despite a soft industrial end market.

But we need to be honest about context. The ISM Manufacturing PMI hit 55.6 in July 2026 — the strongest reading since May 2022 and the seventh consecutive month of expansion. Manufacturing is clearly expanding, yet AdvanSix's nylon business is still being described by management as operating in a soft industrial environment. That tells me the nylon and chemical intermediates recovery is lagging the broader economic signal.

I buy cyclicals when leading indicators bottom, not when GDP is already growing. The ISM data suggests the industrial demand tailwind for nylon should arrive — but it hasn't yet. Until volumes in Nylon Solutions and Chemical Intermediates start converting that demand signal into sustained margin recovery, these segments are a hopeful backdrop, not a thesis driver.

The Dividend Problem

Now to the question that matters most for income investors. AdvanSix declared its $0.16 quarterly dividend, payable September 1st. At the current share price of approximately $20.14, that implies a forward yield of about 3.17%.

The TTM (trailing twelve-month) payout ratio is 165.3%. Free cash flow over the trailing twelve months is negative $22.2 million. Operating cash flow for the same period is $96 million, but capital expenditures of $118 million swallowed through it.

In Q2 alone, free cash flow was negative $10.7 million. Cash and cash equivalents stood at just $7.2 million at quarter-end, down from $19.8 million at the end of 2025. Meanwhile, the long-term line-of-credit balance increased to $275 million from $215 million.

A 165% payout ratio with negative free cash flow and a cash balance that can barely fund a month of operations — that is not the profile of a dividend that compounds. That is the profile of a dividend that needs defending. And the defense strategy, as far as it goes, is management's expectation of sequential cash-flow improvement in the second half from reduced capex (full-year guidance of $75-95 million, down from $116 million in 2025), favorable working capital timing, and a Q4 pre-buy program in Plant Nutrients.

None of those are structural improvements. They're cyclical tailwinds and accounting timing. If Plant Nutrients volumes don't recover meaningfully in H2, or if sulfur costs stay elevated while ammonium sulfate pricing declines as the company has warned, the cash-flow math gets harder, not easier.

Valuation: Cheap or a Value Trap?

At $0.68 times book value and an enterprise value of $795 million against a $543 million market cap, AdvanSix looks cheap by traditional metrics. The EV/EBITDA multiple sits at 10.6 times, which is below many diversified chemical peers. Forward PE is roughly 5 times, implying the market expects meaningful earnings recovery in the coming quarters.

But cheap in a cyclical trough is not the same as cheap because the business is structurally sound. I don't think the question here is whether AdvanSix trades at a discount. The question is whether that discount is compensation for real risk — weak agricultural demand, pass-through pricing with no margin expansion, declining volumes, and a dividend that the business doesn't yet fund from cash flow.

Compared to Eastman Chemical, which trades at 19 times earnings with a 4.6% yield and positive cash generation, or Celanese, which is deeper in the cyclical trough but carries a vastly larger balance sheet, AdvanSix sits in an awkward middle ground. Too small to be immune to commodity shocks. Too leveraged to weather them without balance-sheet stress.

The Setup Going Forward

Management's H2 outlook rests on three pillars: reduced capex, working capital tailwinds including a Q4 pre-buy program, and 45Q carbon capture tax credits supporting cash flow. Plant turnaround impact is expected to be $17 million this year, down from $25 million in 2025.

The strategic bright spot is the planned Diesel Exhaust Fluid (DEF) expansion at Hopewell, Virginia — a multi-year investment targeting operational startup in 2029, with a final investment decision in H1 2027. That is the kind of growth program that can reshape the revenue mix over time. But it is also three years away, and AdvanSix has to survive the next twelve months first.

I believe the agricultural cycle will eventually turn. Ammonium sulfate pricing has been pressured by export competition and farmer economics, but fertilizer demand is a function of crop prices and planting intentions, both of which are mean-reverting over time. The nylon industrial tailwind is already showing up in the ISM data, even if AdvanSix hasn't fully captured it yet.

But mean-reverting does not mean imminent. And a dividend that costs $0.64 per share annually while the business generates negative free cash flow is a luxury the balance sheet cannot afford for long.

This is not a stock I would buy for income today. The payout durability test — can this company fund its dividend from operating cash flow through a full cycle without relying on borrowing or balance-sheet erosion — is not passed. From a risk/reward perspective, the optionality of a cyclical turnaround exists, but the margin between upside and a dividend cut is too narrow to justify treating this as a retirement-income holding. The equity yield curve sweet spot is 2-4% yields with genuine dividend growth. AdvanSix has the yield but lacks the growth trajectory, the cash-flow foundation, and the pricing power to reach it.

If you're watching this name for a setup, the trigger would be: consecutive quarters of positive free cash flow, Plant Nutrients volumes stabilizing or improving, and a payout ratio that falls back below 100%. Until then, the 3.17% yield is a siren, not a signal.